Semaglutide for the treatment of obesity.

Saved in:
Bibliographic Details
Title: Semaglutide for the treatment of obesity.
Authors: Chao AM; University of Pennsylvania School of Nursing, Department of Biobehavioral Health Sciences; Perelman School of Medicine at the University of Pennsylvania, Department of Psychiatry. Electronic address: arichao@upenn.edu., Tronieri JS; Perelman School of Medicine at the University of Pennsylvania, Department of Psychiatry., Amaro A; Perelman School of Medicine at the University of Pennsylvania, Division of Endocrinology, Diabetes and Metabolism and Penn Metabolic Medicine., Wadden TA; Perelman School of Medicine at the University of Pennsylvania, Department of Psychiatry.
Source: Trends in cardiovascular medicine [Trends Cardiovasc Med] 2023 Apr; Vol. 33 (3), pp. 159-166. Date of Electronic Publication: 2021 Dec 21.
Publication Type: Journal Article; Review; Research Support, N.I.H., Extramural
Journal Info: Publisher: Elsevier Science Publishing Country of Publication: United States NLM ID: 9108337 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2615 (Electronic) Linking ISSN: 10501738 NLM ISO Abbreviation: Trends Cardiovasc Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2615
DOI:10.1016/j.tcm.2021.12.008